• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

累及蝶窦的侵袭性垂体腺瘤的生物学标志物。

Biologic markers of invasive pituitary adenomas involving the sphenoid sinus.

作者信息

Gandour-Edwards R, Kapadia S B, Janecka I P, Martinez A J, Barnes L

机构信息

Department of Pathology, University of California, Davis, USA.

出版信息

Mod Pathol. 1995 Feb;8(2):160-4.

PMID:7777477
Abstract

The biologic behavior of invasive pituitary adenomas is poorly understood and appears to be intermediate between intrasellar adenomas and pituitary carcinoma. Utilizing immunohistochemistry on tissue sections, we examined 10 invasive pituitary adenomas involving the sphenoid sinus with a panel of cellular and molecular markers and compared the results with 10 noninvasive pituitary adenomas and five normal pituitary glands. The panel included Ki-67 and PCNA (proliferation cell nuclear antigen), cell proliferation indicators; interleukin 6 (IL-6), a multifunctional cytokine; heat shock protein 27 (HSP 27), a stress response protein; and p53, a tumor suppressor gene product. We found strong expression of IL-6 in normal pituitary glands, 20% of noninvasive and 50% of invasive adenomas. HSP 27 was absent in normal glands and present in 10% of noninvasive and 50% of invasive adenomas. The Ki-67 and PCNA proliferation index was above normal but was essentially the same in the two groups. p53 was not detected in any specimens. We propose that both IL-6 and HSP 27 may be markers of biologic aggression in pituitary adenomas.

摘要

侵袭性垂体腺瘤的生物学行为目前了解甚少,其表现似乎介于鞍内腺瘤和垂体癌之间。我们运用组织切片免疫组化技术,使用一组细胞和分子标志物对10例侵犯蝶窦的侵袭性垂体腺瘤进行检测,并将结果与10例非侵袭性垂体腺瘤及5个正常垂体进行比较。这组标志物包括细胞增殖指标Ki-67和增殖细胞核抗原(PCNA)、多功能细胞因子白细胞介素6(IL-6)、应激反应蛋白热休克蛋白27(HSP 27)以及肿瘤抑制基因产物p53。我们发现,IL-6在正常垂体、20%的非侵袭性腺瘤及50%的侵袭性腺瘤中呈强表达。HSP 27在正常腺体中未检测到,在10%的非侵袭性腺瘤及50%的侵袭性腺瘤中存在。Ki-67和PCNA增殖指数高于正常水平,但两组间基本相同。所有标本均未检测到p53。我们认为,IL-6和HSP 27都可能是垂体腺瘤生物学侵袭性的标志物。

相似文献

1
Biologic markers of invasive pituitary adenomas involving the sphenoid sinus.累及蝶窦的侵袭性垂体腺瘤的生物学标志物。
Mod Pathol. 1995 Feb;8(2):160-4.
2
p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.垂体腺瘤和癌中p53的表达:与侵袭性和肿瘤生长分数的相关性
Neurosurgery. 1996 Apr;38(4):765-70; discussion 770-1.
3
Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.无功能(静止性)垂体腺瘤的临床肿瘤生长及其与增殖标志物的比较
Exp Clin Endocrinol Diabetes. 2008 Feb;116(2):80-5. doi: 10.1055/s-2007-991131. Epub 2007 Dec 10.
4
Pathobiology of pituitary adenomas and carcinomas.垂体腺瘤与癌的病理生物学
Neurosurgery. 2006 Aug;59(2):341-53; discussion 341-53. doi: 10.1227/01.NEU.0000223437.51435.6E.
5
[Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].[p53蛋白表达及MIB-1增殖潜能对垂体腺瘤肿瘤复发的意义]
No To Shinkei. 1998 Jan;50(1):27-32.
6
[Relationship between basic fibroblast growth factor (bFGF) and cell proliferation, invasion in pituitary adenoma].[碱性成纤维细胞生长因子(bFGF)与垂体腺瘤细胞增殖、侵袭的关系]
Hunan Yi Ke Da Xue Xue Bao. 2001 Oct 28;26(5):466-8.
7
Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA.Vater乳头腺瘤中的腺瘤及微小癌——p53和增殖细胞核抗原
Hepatogastroenterology. 1999 May-Jun;46(27):1959-62.
8
Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.复发性人垂体腺瘤的流式细胞术DNA倍体及细胞周期分数。流式细胞术分析与增殖细胞核抗原表达的相关性研究。
Gen Diagn Pathol. 1996 Oct;142(2):89-95.
9
Immunohistochemical analysis of RCAS1 in human pituitary adenomas.人垂体腺瘤中RCAS1的免疫组织化学分析
Mod Pathol. 2001 Dec;14(12):1232-6. doi: 10.1038/modpathol.3880467.
10
Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.垂体腺瘤中细胞增殖标志物的表达——MIB-1与抗拓扑异构酶-IIα的相关性及临床意义
Acta Neurochir (Wien). 2004 Aug;146(8):831-9. doi: 10.1007/s00701-004-0298-0. Epub 2004 Jun 14.

引用本文的文献

1
Association of Ki-67 Labelling Index and IL-17A with Pituitary Adenoma.Ki-67 标记指数和 IL-17A 与垂体腺瘤的关联。
Biomed Res Int. 2018 May 31;2018:7490585. doi: 10.1155/2018/7490585. eCollection 2018.
2
Gene mutations in Cushing's disease.库欣病中的基因突变。
Biomed Rep. 2016 Sep;5(3):277-282. doi: 10.3892/br.2016.729. Epub 2016 Jul 29.
3
Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications.不典型垂体腺瘤的组织学标准——德国垂体腺瘤登记处的数据提示需要进行修正。
Acta Neuropathol Commun. 2015 Aug 19;3:50. doi: 10.1186/s40478-015-0229-8.
4
Clinicopathological correlations in pituitary adenomas.垂体腺瘤的临床病理相关性。
Brain Pathol. 2012 Jul;22(4):443-53. doi: 10.1111/j.1750-3639.2012.00599.x.
5
The clinical significance of MIB-1 labeling index in pituitary adenomas.垂体腺瘤中 MIB-1 标记指数的临床意义。
Pituitary. 2010 Dec;13(4):337-44. doi: 10.1007/s11102-010-0242-7.
6
Determination of cell proliferation using Mcm2 antigen and evaluation of apoptosis and TGF-beta1 expression in GH-secreting or clinically nonfunctioning pituitary adenomas.应用 Mcm2 抗原检测细胞增殖,并评估 GH 分泌性或无功能性垂体腺瘤中的细胞凋亡和 TGF-β1 表达。
Endocr Pathol. 2010 Mar;21(1):32-9. doi: 10.1007/s12022-010-9107-x.
7
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications.癌症中的热休克蛋白:诊断、预后、预测及治疗意义
Cell Stress Chaperones. 2005 Summer;10(2):86-103. doi: 10.1379/csc-99r.1.
8
Clinical significance of Ki-67 labeling index in pituitary macroadenoma.Ki-67标记指数在垂体大腺瘤中的临床意义
J Korean Med Sci. 2005 Jun;20(3):489-94. doi: 10.3346/jkms.2005.20.3.489.
9
Best Practice No 172: pituitary gland pathology.最佳实践第172号:垂体病理学
J Clin Pathol. 2003 Aug;56(8):561-8. doi: 10.1136/jcp.56.8.561.
10
Correlation between PCNA expression and AgNOR dots in pituitary adenomas.垂体腺瘤中增殖细胞核抗原(PCNA)表达与核仁组成区嗜银蛋白(AgNOR)颗粒的相关性
Endocr Pathol. 2001 Summer;12(2):163-9. doi: 10.1385/ep:12:2:163.